Breast Uptake of Radio-iodine in Differentiated Thyroid Cancer

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer

Objective(s): We investigated a frequency of lower extremity uptake on the radioactive iodine (RAI) whole body scan (WBS) after RAI treatment in patients with differentiated thyroid cancer, in order to retrospectively examine whether or not the frequency was pathological. Methods: This retrospective study included 170 patients with thyroid cancer, undergoing RAI treatment. Overall, 99r (58%) an...

متن کامل

extremity radioactive iodine uptake on post-therapeutic whole body scan in patients with differentiated thyroid cancer

objective(s): we investigated a frequency of lower extremity uptake on the radioactive iodine (rai) whole body scan (wbs) after rai treatment in patients with differentiated thyroid cancer, in order to retrospectively examine whether or not the frequency was pathological. methods: this retrospective study included 170 patients with thyroid cancer, undergoing rai treatment. overall, 99r (58%) an...

متن کامل

Role of Radio-Iodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer

The appropriate dose of I131 thyroid ablation is a source of continuing controversy. High fixed dose (75-150 mCi) have been advocate by some authors, obviating the need for reablation [2-3]. Low dose ablation, i.e. a fixed dose of 30 mCi has also been advocated avoiding hospitalization in isolated room with low radiation dose to the patient particularly young individuals who may wish to have ch...

متن کامل

Feasibility of a randomized trial on adjuvant radio-iodine therapy in differentiated thyroid cancer.

BACKGROUND Justification for adjuvant radio-iodine (I-131) therapy in differentiated thyroid cancer (DTC) is purely based on retrospective data. This is true for ablative therapy and even more so for high-dosage adjuvant schedules. Randomized trials on the latter application are considered impossible due to anticipated formidable sample sizes required in a disease with an overall excellent prog...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Radiology and Medical Diagnostic Imaging

سال: 2020

ISSN: 2613-7836,2613-7836

DOI: 10.31487/j.rdi.2020.02.08